Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets
NHS hospitals in England used £23,901,921 of indicative cost of Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 2.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £2,539,956 |
| Royal Free London Nhs Foundation Trust | £1,648,528 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,640,026 |
| Barts Health Nhs Trust | £1,547,850 |
| King's College Hpl Nhs Foundation Trust | £1,369,510 |
| Imperial College Healthcare Nhs Trust | £1,257,505 |
| Chelsea & Westminster Hospital Nhs Ft | £1,168,537 |
| University College London Foundation Tr | £861,521 |
| St George's Univ Hosps Foundation Nhst | £820,406 |
| London North West Healthcare Nhs Trust | £765,177 |
The primary-care picture
Darunavir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Darunavir medicine page.